Cargando…

Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

Leukemias are clonal proliferative disorders arising from immature leukocytes in the bone marrow. While the advent of targeted therapies has improved survival in certain subtypes, relapse after initial therapy is a major problem. Dendritic cell (DC) vaccination has the potential to induce tumor-spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Brien, Liam J., Guillerey, Camille, Radford, Kristen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627518/ https://www.ncbi.nlm.nih.gov/pubmed/31234526 http://dx.doi.org/10.3390/cancers11060875

Ejemplares similares

Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
por: Buckle, Irina, et al.
Publicado: (2021)

Human CD141(+) dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model
por: Lee, Yoke Seng, et al.
Publicado: (2021)

Mitochondrial reactive oxygen species regulate the induction of CD8(+) T cells by plasmacytoid dendritic cells
por: Oberkampf, Marine, et al.
Publicado: (2018)

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
por: Rautenberg, Christina, et al.
Publicado: (2019)

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
por: Oth, Tammy, et al.
Publicado: (2016)

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
por: de Gruijl, Tanja, et al.
Publicado: (2013)

Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
por: Shi, Wei, et al.
Publicado: (2020)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
por: Van Acker, Heleen H., et al.
Publicado: (2019)

Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy
por: Tullett, Kirsteen M., et al.
Publicado: (2014)

Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
por: Nohria, Ambika, et al.
Publicado: (2021)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
por: DeAngelo, Daniel J., et al.
Publicado: (2020)

The GARP complex prevents sterol accumulation at the trans-Golgi network during dendrite remodeling
por: O’Brien, Caitlin E., et al.
Publicado: (2022)

Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
por: Wilson, John, et al.
Publicado: (2009)

Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
por: Wilson, John, et al.
Publicado: (2009)

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
por: Gore, Lia, et al.
Publicado: (2018)

The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)

Relapse prevention
por: Menon, Jayakrishnan, et al.
Publicado: (2018)

Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives
por: Leotta, Salvatore, et al.
Publicado: (2022)

Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?
por: O’Brien, Thomas J, et al.
Publicado: (2023)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021)

Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic
por: Drews, Steven J., et al.
Publicado: (2022)

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
por: Rutkowski, S, et al.
Publicado: (2004)

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wunderlich, Mark, et al.
Publicado: (2021)

Precision Preventive Medicine of Relapse in Smoking Cessation: Can MRI Inform the Search of Intermediate Phenotypes?
por: Rabat, Yolaine, et al.
Publicado: (2021)

Human CD141(+) Dendritic Cell and CD1c(+) Dendritic Cell Undergo Concordant Early Genetic Programming after Activation in Humanized Mice In Vivo
por: Minoda, Yoshihito, et al.
Publicado: (2017)

Burden of vaccine-preventable diseases among at-risk adult populations in the US
por: Kolobova, Irina, et al.
Publicado: (2022)

Leukemia Cutis as an Early Presentation or Relapsing Manifestation of Chronic Lymphocytic Leukemia (CLL)
por: Aldapt, Mahmood B, et al.
Publicado: (2021)

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
por: Shustik, C., et al.
Publicado: (2017)

Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141(+) dendritic cells to activate naïve and memory NY-ESO-1-specific CD8(+) T cells
por: Masterman, Kelly-Anne, et al.
Publicado: (2020)

Dendritic cell vaccines for high-grade gliomas
por: Eagles, Matthew E, et al.
Publicado: (2018)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020)

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
por: Sander, Frida Ewald, et al.
Publicado: (2017)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Maffini, Enrico, et al.
Publicado: (2022)

Relapse prevention for addictive behaviors
por: Hendershot, Christian S, et al.
Publicado: (2011)

Management of relapsed/refractory Chronic Lymphocytic Leukemia
por: Woyach, Jennifer A.
Publicado: (2022)

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant
por: Coombs, Catherine C., et al.
Publicado: (2023)

Non-vaccine-Preventable Infections
por: Torresi, Joseph, et al.
Publicado: (2019)

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
por: Bhojwani, Deepa, et al.
Publicado: (2018)

Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia
por: Rickmann, Mareike, et al.
Publicado: (2013)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dnvsqa3pt8tf73ghu9q78bg5eo